Radiotherapy Used in as Few as 12–22% of Prostate Cases in Europe
Gothenburg – November 04, 2026 -- Radiotherapy is applied in as few as 12–22% of radically treated prostate cancer patients in some European national registries, even though nearly all men with non-metastatic disease requiring active treatment are candidates for it under European Association of Urology (EAU) guidelines. Clinicians and Swedish medtech firm Micropos Medical are now pushing to raise awareness of high-precision radiotherapy as an alternative to surgery.